KLI
SNY icon

Kelman-Lazarov Inc’s Sanofi SNY Stock Holding History

Kelman-Lazarov Inc’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,800
Closed -$72.8K – 225
2016
Q4 		$72.8K Hold
1,800
– – 0.04% 151
2016
Q3 		$69.1K Sell
1,800
-600
-25% -$24.1K 0.04% 163
2016
Q2 		$100K Sell
2,400
-300
-11% -$12.3K 0.06% 144
2016
Q1 		$109K Buy
+2,700
New +$108K 0.06% 147

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Kelman-Lazarov Inc's SNY Position: Q1 2017 in Review

Kelman-Lazarov Inc sold out of Sanofi (SNY) in Q1 2017, closing a stake of 1,800 shares — an estimated $72.8K sold.

Kelman-Lazarov Inc first reported a position in SNY in Q1 2016 and held it in 4 quarters. The position peaked at $109K in Q1 2016. 455 funds tracked by Wall St. Rank hold SNY as of Q1 2017.

  • Kelman-Lazarov Inc reported no remaining Sanofi position as of Q1 2017 after selling out during the quarter.
  • Kelman-Lazarov Inc sold 1,800 Sanofi shares in Q1 2017, an estimated $72.8K.
  • Kelman-Lazarov Inc first reported a position in Sanofi in Q1 2016 and held it in 4 quarters.
  • Kelman-Lazarov Inc's Sanofi position peaked at $109K in Q1 2016.
  • 455 funds tracked by Wall St. Rank held Sanofi as of Q1 2017.

Based on Kelman-Lazarov Inc's 13F filing for Q1 2017, filed 25 Apr 2017.